Dark Forest Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-32,464
| Closed | -$243K | – | 1181 |
|
|
2025
Q1 | $243K | Buy |
32,464
+2,771
| +9% | +$20.8K | 0.01% | 1109 |
|
|
2024
Q4 | $223K | Sell |
29,693
-19,683
| -40% | -$148K | 0.03% | 783 |
|
|
2024
Q3 | $375K | Buy |
+49,376
| New | +$375K | 0.05% | 510 |
|
|
2022
Q4 | – | Sell |
-6,732
| Closed | -$85K | – | 1150 |
|
|
2022
Q3 | $85K | Buy |
6,732
+6,694
| +17,616% | +$84.5K | 0.01% | 483 |
|
|
2022
Q2 | $0 | Buy |
+38
| New | – | ﹤0.01% | 904 |
|
|
2021
Q3 | – | Sell |
-1,919
| Closed | -$30K | – | 1267 |
|
|
2021
Q2 | $30K | Buy |
+1,919
| New | +$30K | 0.01% | 516 |
|